It turned up in the facilities of the second largest generic pharmaceuticals company in the world who said they'll keep it and in return give ECS the business to supply them with all of the medicinal cannabis product they require.
The CEO of CAN said he wants to see more involvement from big Pharma in the local industry, perhaps this is a good example.
- Forums
- ASX - By Stock
- Ann: Cann Group FY23 unaudited revenue results
CAN
cann group limited
Add to My Watchlist
0.00%
!
1.4¢

It turned up in the facilities of the second largest generic...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.118M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.3¢ | $7.484K | 534.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 3246538 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 55557 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 3246538 | 0.013 |
7 | 1908666 | 0.012 |
7 | 1423750 | 0.011 |
18 | 2551605 | 0.010 |
4 | 393613 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 55557 | 1 |
0.015 | 261156 | 3 |
0.016 | 2566909 | 7 |
0.017 | 1872701 | 6 |
0.018 | 1192313 | 5 |
Last trade - 15.52pm 30/07/2025 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |